Dergiler / Acta Medica / 2019 / Cilt: 50 - Sayı: 2

The Assessment of Red Blood Cell Distribution Width, Platelet Parameters and Inflammatory Markers in Patients on Antıpsoriasis Therapy

Sayfa
39–46
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Red blood cell dis-tribution width and high sensitivity C reactive protein might be useful to de-tect systemic inflammation in psoriasis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Psoriasis is an inflammatory skin disease with several comorbid-ities.
📊
Temel Bulgular & Veri:Materials and Methods: 94 psoriasis patients and 74 healthy controls were prospectively analyzed.
💡
Sonuç & Katkı:Red blood cell dis-tribution width and high sensitivity C reactive protein might be useful to de-tect systemic inflammation in psoriasis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Psoriasis is an inflammatory skin disease with several comorbid-ities. We aimed to evaluate red blood cell distribution width (RDW), platelet parameters and inflammatory markers in patients on antipsoriasis therapies. Materials and Methods: 94 psoriasis patients and 74 healthy controls were prospectively analyzed. Before and after 8 weeks of different therapies (cal-cipotriol+clobetasol propionate; narrow-band UVB; combined narrow-band UVB and acitretin; infliximab and adalimumab), red blood cell distribution width, platelet parameters, high sensitivity C reactive protein, and erythro-cyte sedimentation rate levels were measured. Lipid profile and fasting blood glucose tests were also performed prior the treatment. Psoriasis severity and area index and body mass index were calculated for each patient. Results: red blood cell distribution width, high sensitivity C reactive protein, triglyceride, total cholesterol levels and body mass index were higher in pa-tients than in controls (p 0.05, for all). Red blood cell distribution width was not cor-related with psoriasis severity and area index (p>0.05). The limitations of our study are the relatively small samples of therapy groups and short duration of follow-up.Conclusion: The role of antipsoriasis therapies on inflammatory markers should be elucidated via additional larger-scale studies. Red blood cell dis-tribution width and high sensitivity C reactive protein might be useful to de-tect systemic inflammation in psoriasis.

🔖

Bu Makaleye Atıf Yap

KALAYCI, O. M. (2019). The Assessment of Red Blood Cell Distribution Width, Platelet Parameters and Inflammatory Markers in Patients on Antıpsoriasis Therapy. Acta Medica, Cilt: 50 - Sayı: 2, 39–46. https://ajindex.com/articles/141986

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and sys-temic inflammatory diseases: potential mechanistic linksbetween skin disease and comorbid conditions. J InvestDermatol 2010; 130: 1785-96.
  2. Srikanthan K, Feyh A, Visweshwar H, et al. SystematicReview of Metabolic Syndrome Biomarkers: A Panel forEarly Detection, Management, and Risk Stratificationin the West Virginian Population. Int J Med Sci. 2016; 13:25-38.
  3. Esser N, Paquot N, Scheen AJ. Inflammatory markers andcardiometabolic diseases. Acta Clin Belg. 2015; 70: 193-9.
  4. Dagistan Y, Dagistan E, Citisli V. Evaluation of simple blood counts as inflammation markers for brain tumor patients.Neurol Neurochir Pol. 2016; 50: 231-5.
  5. Al-Najjar Y, Goode KM, Zhang J, et al. Red cell distributionwidth: an inexpensive and powerful prognostic marker inheart failure. Eur J Heart Fail. 2009; 11: 1155-62.
  6. Cakal B, Akoz AG, Ustundag Y, et al. Red cell distributionwidth for assessment of activity of inflammatory boweldisease. Dig Dis Sci. 2009; 54: 842-7.
  7. Clarke K, Sagunarthy R, Kansal S. RDW as an additionalmarker in inflammatory bowel disease/undifferentiatedcolitis. Dig Dis Sci. 2008; 53: 2521-3.
  8. Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulnessof red cell distribution width as a prognostic marker inpulmonary hypertension. Am J Cardiol. 2009; 104: 868-72. Lappé JM, Horne BD, Shah SH, et al. Red cell distributionwidth, C-reactive protein, the complete blood count, andmortality in patients with coronary disease and a normalcomparison population. Clin Chim Acta. 2011; 412: 2094-9.
  9. Lee WS, Kim TY. Relation between red blood cell distribu-tion width and inflammatory biomarkers in rheumatoidarthritis. Arch Pathol Lab Med. 2010; 134: 505-6.
  10. Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory bio-markers in a large cohort of unselected outpatients. ArchPathol Lab Med. 2009; 133: 628-32.
  11. Molnar T, Farkas K, Szepes Z, et al. RDW can be a useful ad-ditional marker in diagnosing Crohn’s disease and ulcer-ative colitis. Dig Dis Sci. 2008; 53: 2828–9.
  12. Patel KV, Semba RD, Ferrucci L, et al. Red cell distributionwidth and mortality in older adults: a meta-analysis. JGerontol A Biol Sci Med Sci. 2010; 65: 258-65.
  13. Pan Y, Muheremu A, Wu X, et al. Relationship betweenplatelet parameters and hepatic pathology in patientswith chronic hepatitis B infection - a retrospective cohortstudy of 677 patients. J Int Med Res. 2016; 44: 779-86. Matowicka-Karna J. Markers of inflammation